The Inhibition of Prolyl Endopeptidase (PREP) by KYP-2047 Treatment to Reduce Myocardial Ischemia/Reperfusion Injury

The Inhibition of Prolyl Endopeptidase (PREP) by KYP-2047 Treatment to Reduce Myocardial Ischemia/Reperfusion Injury

Myocardial ischemia–reperfusion injury (MI/R) is a negative and adverse cardiovascular outcome following myocardial ischemia, cardiac surgery, or circulatory arrest. Prolyl endopeptidase (PREP) appears to be involved in inflammatory responses, so it could be a possible therapeutic target for counter...

Full description

Saved in:

Bibliographic Details
Main Authors:	Laura Cucinotta, Nicoletta Palermo, Alessio Ardizzone, Anna Paola Capra, Michela Campolo, Emanuela Esposito, Giovanna Casili, Marika Lanza
Format:	Article
Language:	English
Published:	MDPI AG 2025-04-01
Series:	Antioxidants
Subjects:	myocardial ischemia/reperfusion injury (MI/R) prolyl endopeptidase KYP-2047 MAPK NF-κB
Online Access:	https://www.mdpi.com/2076-3921/14/4/442
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Ionic liquid ultrasound-assisted extraction (IL-UAE) for duck feather keratin and in silico evaluation as a potential procollagen n-endopeptidase inhibitor
by: Maria Monica Sianita, et al.
Published: (2025-07-01)

Issues on clinical application of hypoxia-inducible factor prolyl hydroxylase inhibitor Roxadustat
by: TU Yan, et al.
Published: (2020-01-01)

Tumor suppressive activity of prolyl isomerase Pin1 in renal cell carcinoma
by: Brian L. Teng, et al.
Published: (2011-10-01)

Control of fibrosis with enhanced safety via asymmetric inhibition of prolyl‐tRNA synthetase 1
by: Ina Yoon, et al.
Published: (2023-05-01)

Endothelial Cell‐Specific Prolyl Hydroxylase‐2 Deficiency Augments Angiotensin II–Induced Arterial Stiffness and Cardiac Pericyte Recruitment in Mice
by: Bo Liu, et al.
Published: (2024-08-01)

Phi-Value and NMR Structural Analysis of a Coupled Native-State Prolyl Isomerization and Conformational Protein Folding Process
by: Ulrich Weininger, et al.
Published: (2025-02-01)

Prolyl‐isomerase Pin1 controls normal and cancer stem cells of the breast
by: Alessandra Rustighi, et al.
Published: (2013-12-01)

Prolyl Hydroxylase Inhibitor-Mediated HIF Activation Drives Transcriptional Reprogramming in Retinal Pigment Epithelium: Relevance to Chronic Kidney Disease
by: Tamás Gáll, et al.
Published: (2025-07-01)

Editorial: Phosphorylation-dependent peptidyl-prolyl cis/trans isomerase PIN1 - volume II
by: Futoshi Suizu
Published: (2024-11-01)

Genetic characteristics of novel extreme alkaline-inducible promoter located in five prime upstream region of peptidyl-prolyl cis/trans isomerase from Vibrio anguillarum
by: Dong-Gyun Kim, et al.
Published: (2025-07-01)

Effects of hypoxia-inducible factor prolyl hydroxylase inhibitors on hemoglobin, B-type natriuretic peptide, and renal function in anemic heart failure patients: A systematic review and meta-analysis
by: Hidekatsu Fukuta, et al.
Published: (2025-06-01)

Genes related to maintenance of autophagy and successful aging
by: Carolina Fioroto Chaves, et al.

Safety evaluation of the food enzyme prolyl oligopeptidase from the genetically modified Trichoderma reesei strain DP‐Nyq99
by: EFSA Panel on Food Enzymes (FEZ), et al.
Published: (2025-05-01)

Structure-Based Virtual Screening of Potential Inhibitors Targeting the Prolyl-tRNA Synthetase (PRS) in <i>Eimeria tenella</i>: Insights from Molecular Docking, ADMET Studies, and Molecular Dynamics Simulations
by: Haiming Cai, et al.
Published: (2025-02-01)

Association of <i>Helicobacter pylori</i> with Serum HIF-1α, HIF-2α, and Human Transmembrane Prolyl 4-Hydroxylase Activity in Patients with Chronic Gastritis
by: Sefa Ergün, et al.
Published: (2025-06-01)

miR‐17/20 Controls Prolyl Hydroxylase 2 (PHD2)/Hypoxia‐Inducible Factor 1 (HIF1) to Regulate Pulmonary Artery Smooth Muscle Cell Proliferation
by: Tianji Chen, et al.
Published: (2016-12-01)

PI3K/mTOR Signaling Pathway Dual Inhibition for the Management of Neuroinflammation: Novel Insights from In Vitro Models
by: Alessio Ardizzone, et al.
Published: (2025-05-01)

On Lionel Shriver’s The Mandibles, A Family (2029-2047)
by: Cyril Camus
Published: (2020-03-01)

PCPE2: Expression of multifunctional extracellular glycoprotein associated with diverse cellular functions
by: Michael J. Thomas, et al.
Published: (2024-11-01)

Human prolyl hydroxylase domain 2 reacts with O2 and 2-oxoglutarate to enable formation of inactive Fe(III).2OG.hypoxia-inducible-factor α complexes
by: Giorgia Fiorini, et al.
Published: (2024-10-01)

Supramolecular complex sacubitril/valsartan - the first representative of a new class of drugs for the treatment of chronic heart failure
by: T. V. Ashcheulova, et al.
Published: (2019-12-01)

Safety evaluation of the food enzyme subtilisin from the non‐genetically modified Bacillus paralicheniformis strain LMG S‐30155
by: EFSA Panel on Food Contact Materials, Enzymes and Processing Aids (CEP), et al.
Published: (2023-06-01)

Safety evaluation of the food enzyme mucorpepsin from the non‐genetically modified Rhizomucor miehei strain LP‐N836
by: EFSA Panel on Food Contact Materials, Enzymes and Processing Aids (CEP), et al.
Published: (2024-03-01)

Safety evaluation of the food enzyme subtilisin from the non‐genetically modified Bacillus paralicheniformis strain AP‐01
by: EFSA Panel on Food Contact Materials, Enzymes and Processing Aids (CEP), et al.
Published: (2024-07-01)

A Case Report of Hypothyrotropin Hypothyroidism Caused by Roxadustat
by: YAN Xuelian, et al.
Published: (2025-03-01)

PHD3 inhibits cell proliferation through hydroxylation of PAX2 at proline 9
by: Lun Jie, et al.
Published: (2022-04-01)

UK kidney association clinical practice guideline: update of anaemia of chronic kidney disease
by: Sunil Bhandari, et al.
Published: (2025-04-01)

Nanoscale Systems for Local Activation of Hypoxia-Inducible Factor-1 Alpha: A New Approach in Diabetic Wound Management
by: Saber S, et al.
Published: (2024-12-01)

CYCLOPHILIN A: STRUCTURE AND FUNCTIONS
by: A. A. Kalinina, et al.
Published: (2017-12-01)

Multidimensional pan-cancer analysis reveals the impact of PPIA on tumor epigenetic modifications and immune regulation
by: Yuanqian Yao, et al.
Published: (2025-07-01)

Novel glyproline GZK-111 with neuropsychotropic activity
by: K. N. Koliasnikova, et al.
Published: (2022-02-01)

Increase in blood-transferable linear and cyclic dipeptides in human plasma following ingestion of elastin hydrolysate
by: Yu Iwasaki, et al.
Published: (2024-12-01)

P4HA1: an important target for treating fibrosis related diseases and cancer
by: Xuewen Yang, et al.
Published: (2024-11-01)

Desidustat: a novel PHD inhibitor for the treatment of CKD-induced anemia
by: Amit Joharapurkar, et al.
Published: (2024-10-01)

Roxadustat has risks of reversible central hypothyroidism in patients undergoing hemodialysis: a single-center retrospective cohort study
by: Emiko Otsuka, et al.
Published: (2024-12-01)

Stabilization of Transcription Factor, HIF-1α by Prolylhydroxylase 1 Knockout Reduces Cardiac Injury After Myocardial Infarction in Mice
by: Mahesh Thirunavukkarasu, et al.
Published: (2025-03-01)

HIF-PHIs associated with embolic and thrombotic events: a real-world pharmacovigilance study based on the Japan Adverse Drug Event Report database
by: Danna Wu, et al.
Published: (2025-12-01)

Robust Monotonically Convergent Iterative Learning Control for Discrete-Time Systems via Generalized KYP Lemma
by: Jian Ding, et al.
Published: (2014-01-01)

The role and clinical implications of HIF-PHI daprodustat in dialysis-dependent and non-dialysis-dependent chronic kidney disease anemic patients: a general review
by: Yousuf Abdulkarim Waheed, et al.
Published: (2024-12-01)

Neuronal C/EBPβ Shortens the Lifespan via Inactivating NAMPT
by: Bowei Li, et al.
Published: (2025-06-01)